Legal Representation
Attorney
Sarah Otte Graber
USPTO Deadlines
Next Deadline
2040 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-02-11)
Due Date
February 11, 2031
Grace Period Ends
August 11, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
50 events| Date | Code | Type | Description |
|---|---|---|---|
| Feb 11, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Feb 11, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
| Jan 18, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Jan 18, 2025 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
| Jan 18, 2025 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Jan 18, 2025 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Nov 1, 2024 | IUAF | S | USE AMENDMENT FILED |
| Nov 1, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
| Nov 1, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| May 3, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| May 2, 2024 | EXT4 | S | SOU EXTENSION 4 FILED |
| May 2, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED |
| May 2, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Nov 4, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Nov 2, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Nov 2, 2023 | EXT3 | S | SOU EXTENSION 3 FILED |
| Nov 2, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Apr 27, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Apr 27, 2023 | NOAC | E | CORRECTED NOA E-MAILED |
| Apr 26, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Apr 26, 2023 | DPCC | D | DIVISIONAL PROCESSING COMPLETE |
| Apr 26, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Apr 6, 2023 | EXT2 | S | SOU EXTENSION 2 FILED |
| Apr 6, 2023 | ERTD | I | TEAS REQUEST TO DIVIDE RECEIVED |
| Apr 6, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Apr 3, 2023 | DRRR | I | DIVISIONAL REQUEST RECEIVED |
| Nov 5, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Nov 3, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Nov 3, 2022 | EXT1 | S | SOU EXTENSION 1 FILED |
| Nov 3, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| May 3, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Mar 8, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Mar 8, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Feb 16, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Feb 1, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Feb 1, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Feb 1, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Feb 1, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Feb 1, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Jan 29, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jan 28, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jan 28, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Jul 28, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Jul 28, 2021 | GNRT | F | NON-FINAL ACTION E-MAILED |
| Jul 28, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Jul 28, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Jul 28, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Jul 28, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Jul 26, 2021 | DOCK | D | ASSIGNED TO EXAMINER |
| Apr 14, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Detailed Classifications
Class 010
Medical apparatus and instruments for treating arrhythmia and atrial fibrillation; Medical device systems consisting of medical devices for treating arrhythmia and atrial fibrillation; medical devices for treating arrhythmia and atrial fibrillation; Medical device systems for use in renal denervation and other forms of neuromodulation of the autonomic nervous system, consisting of cartridges for medical fluids, carts, guiding catheters, and remote controls for medical devices for use in performing denervation of human beings; energy emitting catheter-based systems consisting of medical devices and devices for medical procedures in the nature of neuromodulation and denervation of the autonomic nervous system for use in treating a variety of medical conditions, including arrhythmia and atrial fibrillation, among other medical conditions, and also consisting of cartridges for medical fluids, carts, guiding catheters, and remote controls for medical devices used in connection with the preceding systems and devices; medical devices for sensing nerve activity and for performing denervation
First Use Anywhere:
20230000
First Use in Commerce:
20230000
Classification
International Classes
010